Journal article
The role of In Vivo and Ex Vivo diagnostic tools in severe delayed Immune-Mediated adverse antibiotic drug reactions
The Journal of Allergy and Clinical Immunology: In Practice, Vol.9(5), pp.2010-2015.e4
2021
Abstract
Background
The use of in vivo and ex vivo diagnostic tools for delayed immune-mediated adverse drug reactions is currently ill defined.
Objective
To determine whether the combination of skin testing and/or IFN-γ enzyme-linked immunoSpot assay (ELISpot) can aid diagnosis of these allergy phenotypes.
Methods
Patients with antibiotic-associated severe delayed immune-mediated adverse drug reaction hypersensitivity, including Stevens-Johnson syndrome and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis, generalized bullous fixed drug eruption, and severe maculopapular exanthema, were prospectively recruited. In vivo testing was completed to the implicated drug(s), and ex vivo testing was performed with the patient's PBMCs stimulated with the relevant antibiotic concentrations for IFN-γ release ELISpot measurement.
Results
Eighty-one patients met the inclusion criteria, with DRESS (42; 51.9%) accounting for most cases. Among the 63 (78%) who had an ELISpot assay performed, 34 (54%) were positive to at least 1 implicated antibiotic (median spot-forming units/million cells, 99.5; interquartile range, 68-187), with glycopeptide being a strong predictor of positivity (adjusted odds ratio, 6.11; 95% CI, 1.74-21.42). In combination (in vivo and ex vivo), 51 (63%) of those tested were positive to an implicated antibiotic. For DRESS and severe maculopapular exanthema associated with penicillins and cephalosporins, this combination confirmed the culprit agent in 11 of the 12 cases and in 6 of 7 for DRESS associated with glycopeptides.
Conclusions
This study demonstrates that using in vivo in combination with ex vivo testing can enhance the diagnostic approach in these severe phenotypes by assisting with the identification of possible culprit antibiotics.
Details
- Title
- The role of In Vivo and Ex Vivo diagnostic tools in severe delayed Immune-Mediated adverse antibiotic drug reactions
- Authors/Creators
- A. Copaescu (Author/Creator) - McGill UniversityE. Mouhtouris (Author/Creator) - Austin HealthS. Vogrin (Author/Creator) - The University of MelbourneF. James (Author/Creator) - Austin HealthK.Y.L. Chua (Author/Creator) - Austin HealthN.E. Holmes (Author/Creator) - The University of MelbourneA. Douglas (Author/Creator) - Peter MacCallum Cancer CentreM.A. Slavin (Author/Creator) - Peter MacCallum Cancer CentreH. Cleland (Author/Creator) - Alfred HealthC. Zubrinich (Author/Creator) - Monash UniversityA.K. Aung (Author/Creator) - Alfred HealthM.S.Y. Goh (Author/Creator) - St Vincent's HealthE.J. Phillips (Author/Creator) - Vanderbilt University Medical CenterJ.A. Trubiano (Author/Creator) - Austin Health
- Publication Details
- The Journal of Allergy and Clinical Immunology: In Practice, Vol.9(5), pp.2010-2015.e4
- Publisher
- Elsevier
- Identifiers
- 991005542829407891
- Copyright
- © 2021 American Academy of Allergy, Asthma & Immunology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
72 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.265 Dermatology - Skin Allergies
- 1.265.1140 Drug Hypersensitivity
- Web Of Science research areas
- Allergy
- Immunology
- ESI research areas
- Clinical Medicine